rutecarpine has been researched along with Alzheimer Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Ji, L; Li, Z; Ma, J; Wang, M; Wu, M | 1 |
| Dong, YH; Huang, XF; Ke, HM; Song, GQ; Wang, JH; Xu, DF | 1 |
| An, XW; Chen, C; Chen, F; Hu, N; Jia, XL; Li, XH; Liu, R; Sun, HT; Wang, JJ; Wang, Y; Zhao, B; Zheng, CG | 1 |
| Chen, JG; Li, X; Wu, YG | 1 |
| Chen, SB; Gu, LQ; He, Y; Huang, SL; Huang, ZH; Huang, ZS; Li, D; Tan, JH; Yao, PF | 1 |
5 other study(ies) available for rutecarpine and Alzheimer Disease
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cell Line, Tumor; Chelating Agents; Cholinesterase Inhibitors; Drug Design; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protective Agents; Protein Multimerization; Rats; Structure-Activity Relationship; Sulfonamides | 2019 |
Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cholinergic Antagonists; Cognitive Dysfunction; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Indole Alkaloids; Mice; Models, Molecular; Molecular Structure; Morris Water Maze Test; Phosphodiesterase 5 Inhibitors; Protein Conformation; Quinazolines; Scopolamine | 2020 |
Rutaecarpine Ameliorated High Sucrose-Induced Alzheimer's Disease Like Pathological and Cognitive Impairments in Mice.
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Glycogen Synthase Kinase 3 beta; Indole Alkaloids; Mice; Phosphorylation; Quinazolines; Sucrose | 2021 |
[Effect of rutaecarpine on Alzheimer's disease-like cognitive impairments induced by high glucose in rats].
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Glucose; Glycogen Synthase Kinase 3 beta; Indole Alkaloids; Male; Maze Learning; Phosphorylation; Quinazolines; Random Allocation; Rats; Rats, Sprague-Dawley; tau Proteins | 2019 |
Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Biocatalysis; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Chelating Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Indole Alkaloids; Inhibitory Concentration 50; Kinetics; Models, Chemical; Models, Molecular; Molecular Structure; Peptide Fragments; Protein Binding; Protein Structure, Tertiary; Quinazolines | 2013 |